The metabolic syndrome (MetS) is a combination of metabolic abnormalities including hypertension, dyslipidemia, abdominal obesity and disturbed glucose and insulin metabolism [1], all of these being well associated with high-risk factors for both type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVDs) [2,3,4]. Here, INS is linked to type 2 diabetes mellitus.